Proto Labs (PRLB)
(Delayed Data from NYSE)
$32.19 USD
-0.88 (-2.66%)
Updated Feb 6, 2023 04:00 PM ET
After-Market: $32.17 -0.02 (-0.06%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Balance Sheet
Fiscal Year End for Proto Labs, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | NA | 78 | 162 | 161 | 132 |
Receivables | NA | 81 | 58 | 57 | 65 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 13 | 11 | 10 | 10 |
Other Current Assets | NA | 11 | 11 | 8 | 9 |
Total Current Assets | NA | 183 | 242 | 236 | 215 |
Net Property & Equipment | NA | 280 | 283 | 264 | 228 |
Investments & Advances | NA | 14 | 59 | 13 | 24 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 439 | 143 | 146 | 149 |
Deposits & Other Assets | NA | 4 | 5 | 3 | 3 |
Total Assets | NA | 929 | 744 | 674 | 619 |
Liabilities & Shareholders Equity | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 25 | 18 | 17 | 17 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 1 | 1 | 0 | 0 |
Accrued Expenses | NA | 26 | 28 | 26 | 35 |
Income Taxes Payable | NA | 0 | 0 | 1 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 55 | 50 | 48 | 53 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 36 | 34 | 26 | 20 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 1 | 2 | 0 | 0 |
Other Non-Current Liabilities | NA | 6 | 6 | 5 | 5 |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 100 | 100 | 88 | 77 |
Shareholders Equity | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 469 | 285 | 268 | 259 |
Retained Earnings | NA | 377 | 363 | 325 | 291 |
Other Equity | NA | -17 | -3 | -7 | -8 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 828 | 644 | 586 | 542 |
Total Liabilities & Shareholder's Equity | NA | 929 | 744 | 674 | 619 |
Total Common Equity | 0 | 828 | 644 | 586 | 542 |
Shares Outstanding | 27.10 | 27.50 | 26.70 | 26.70 | 27.00 |
Book Value Per Share | 0.00 | 30.13 | 24.13 | 21.94 | 20.06 |
Fiscal Year End for Proto Labs, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | NA | 85 | 79 | 77 | 78 |
Receivables | NA | 81 | 85 | 87 | 81 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 15 | 15 | 14 | 13 |
Other Current Assets | NA | 12 | 11 | 10 | 11 |
Total Current Assets | NA | 192 | 191 | 188 | 183 |
Net Property & Equipment | NA | 260 | 261 | 271 | 280 |
Investments & Advances | NA | 29 | 31 | 28 | 14 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 415 | 424 | 435 | 439 |
Deposits & Other Assets | NA | 4 | 6 | 6 | 4 |
Total Assets | NA | 907 | 919 | 935 | 929 |
Liabilities & Shareholders Equity | 12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 17 | 16 | 18 | 25 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 1 | 0 | 0 | 1 |
Accrued Expenses | NA | 41 | 41 | 36 | 26 |
Income Taxes Payable | NA | 0 | 0 | 4 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 61 | 59 | 60 | 55 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 27 | 30 | 33 | 36 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 1 | 1 | 1 |
Other Non-Current Liabilities | NA | 6 | 6 | 6 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 96 | 98 | 103 | 100 |
Shareholders Equity | 12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 477 | 476 | 472 | 469 |
Retained Earnings | NA | 381 | 381 | 382 | 377 |
Other Equity | NA | -47 | -36 | -22 | -17 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 811 | 821 | 832 | 828 |
Total Liabilities & Shareholder's Equity | NA | 907 | 919 | 935 | 929 |
Total Common Equity | 0 | 811 | 821 | 832 | 828 |
Shares Outstanding | 27.10 | 27.50 | 27.50 | 27.40 | 27.50 |
Book Value Per Share | 0.00 | 29.49 | 29.84 | 30.37 | 30.13 |